Grifols Forecasts 25 Percent Core Earnings Growth in 2026
Grifols expects 2026 core earnings to rise by over 25 percent. The firm will prioritize profitability and debt reduction while expanding in Egypt and Canada.
Xurve View
洞察:
Xurve View
The healthcare specialist Grifols, S.A. announced on Thursday that it anticipates a significant surge in core earnings for 2026 as the company pivots its strategy toward profitability and aggressive debt reduction. The Barcelona-based firm, which specializes in plasma-derived medicines, is working to restore investor confidence following a turbulent period marked by short-seller allegations.
